<DOC>
	<DOCNO>NCT00125567</DOCNO>
	<brief_summary>The purpose study demonstrate patient Parkinson 's disease , compare levodopa/carbidopa , Stalevo delay time initiation study drug time increase antiparkinsonian medication require due inadequately controlled parkinsonian symptom .</brief_summary>
	<brief_title>Stalevo Early Wearing-Off Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Entacapone</mesh_term>
	<criteria>Idiopathic Parkinson 's disease Treatment 3 equal daily dos levodopa/carbidopa 450 mg/day Unchanged antiparkinsonian medication 6 week prior baseline Secondary atypical parkinsonism Patients daily unpredictable OFF period painful dyskinesia</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>